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Abstract
Background: Infectious bronchitis virus (IBV) is the coronavirus of domestic chickens causing major economic losses 
to the poultry industry. Because of the complexity of the IBV life cycle and the small number of viral structural proteins, 
important virus-host relationships likely remain to be discovered. Toward this goal, we performed two-dimensional gel 
electrophoresis fractionation coupled to mass spectrometry identification approaches to perform a comprehensive 
proteomic analysis of purified IBV particles.
Results: Apart from the virus-encoded structural proteins, we detected 60 host proteins in the purified virions which 
can be grouped into several functional categories including intracellular trafficking proteins (20%), molecular 
chaperone (18%), macromolcular biosynthesis proteins (17%), cytoskeletal proteins (15%), signal transport proteins 
(15%), protein degradation (8%), chromosome associated proteins (2%), ribosomal proteins (2%), and other function 
proteins (3%). Interestingly, 21 of the total host proteins have not been reported to be present in virions of other virus 
families, such as major vault protein, TENP protein, ovalbumin, and scavenger receptor protein. Following identification 
of the host proteins by proteomic methods, the presence of 4 proteins in the purified IBV preparation was verified by 
western blotting and immunogold labeling detection.
Conclusions: The results present the first standard proteomic profile of IBV and may facilitate the understanding of the 
pathogenic mechanisms.
Background
Infectious bronchitis virus (IBV), the coronavirus of
domestic chickens tha t causes acute, highly contagious
respiratory disease, is one of the most important causes
of economic loss in the poultry industry. IBV is an envel-
oped virus with continuous, positive and single-stranded
RNA genome, which is the largest of any RNA virus char-
acterized[1] and encodes four types of structural pro-
teins. The spike (S) glycoprotein, together with small
envelope (E) protein and matrix (M) glycoprotein, con-
sists of the viral envelope, whereas the nucleocapsid (N)
protein interacts with genomic RNA of the virus to form
the viral nucleocapsid, in the invariable order 5'-S-E-M-
N-3'. Proteins S, E, and M have been studied for their
important roles in receptor binding and virus budding. S
mediates attachment to cellular receptors and entry by
fusion with cell membranes, whereas M interacting with
S and N proteins is an essential component of virion and
plays pivotal roles in virion assembly, budding and matu-
ration [2,3]. In addition, S protein can inhibit host cell
translation by interacting with eIF3f [4] and the interac-
tion between M and actin facilitates virion assembly and
budding [5]. E is a poorly characterized small envelope
protein present in low levels in the virions. The signifi-
cance of the E protein appears to be critical for viral bud-
ding. Another role for protein E is that it can promote
apoptosis [6,7].
Viruses constantly adapt to and modulate the host envi-
ronment during replication and propagation. To govern
egress from the host cell and initiation of replication in
the target cell, viruses will carry some of the host proteins
when released from infected cells. Enveloped viruses par-
ticularly encoding only small proteins have the capability
of incorporating numerous host proteins into or onto the
newly formed viruses. It is an important prerequisite for
the functional studies to know the protein composition of
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the purified viral particles, as it allows the analysis of spe-
cific proteins and their roles during the virus life cycle,
resulting in better understanding of the infection process
and the pathogenesis of viruses.
As a large number of virus complete genomes have
been sequenced since 1980s, more and more host pro-
teins in different enveloped viruses have been studied
using viral proteomic approaches. Herpesviruses have
been the most extensively studied in this respect, such as
Kaposi's sarcoma-associated herpesvirus (KSHV) [8,9],
Marek's disease virus (MDV) [10], Epstein-Barr virus
(EBV) [11], human cyotomegalovirus (HCMV) [12] and
murine cyotomegalovirus (MCMV) [13]. Other double-
stranded DNA (dsDNA) viruses including vacciniavirus
have also contributed to a better understanding of this
intriguing phenomenon [14-16]. Furthermore, recent
studies on identification of the incorporated host proteins
in RNA viruses have also been undertaken. For retrovi-
rus, various studies in this research area have been per-
formed on human immunodeficiency virus type 1 (HIV-
1) [17-20] and moloney murine leukemia virus (MMLV)
[21]. For paramyxovirus, numerous host proteins have
been found incorporated into avian influenza virus (AIV)
particles and respiratory syncytial virus (RSV) particles
[22-24].
To date, no study of the host proteins in the virions of
c o r o n a vi rus  h as  bee n  pe rf o rm ed  y e t.  I n  t h is  s t u d y ,  w e
performed two-dimensional gel electrophoresis fraction-
ation coupled to mass spectrometry identification
approaches to perform a comprehensive proteomic anal-
ysis of purified IBV particles. Our analysis resulted in the
identification of 2 virus-encoded structural proteins and
60 incorporated host proteins. In addition, we also dis-
cussed the functional implications of some host proteins
in IBV infection and pathogenesis.
Results
Purification of IBV particles
Viral proteomic analysis requires a highly purified prepa-
ration of virions. There was no available permissive cell
line capable of supporting productive replication of IBV.
Although primary chick embryo kidney cell (CEK) and
chick kidney cell (CK) are capable of supporting produc-
tive replication of IBV, their poor yields prohibit them
from being used for producing large quantity of IBV. In
order to obtain large quantity of IBV virions, this study
selected 10-day-old SPF embryonated chicken eggs for
the growth of IBV strain H52. The AF with enrichment of
H52 was clarified by differential centrifugation in order to
remove the contamination of nuclei, mitochondria, lyso-
somes, peroxisomes and so on from the chicken embryo.
The virus was concentrated through a 20% (wt/vol)
sucrose cushion before purified over a non-linear 20%-
50% sucrose-TNE (Tris-buffered saline including 50 mM
Tris, 100 mM NaCl, 1 mM EDTA, pH 7.4) gradient. Two
distinct types of IBV particles were isolated by sucrose
density gradients. The higher density particles banded at
30%-40% sucrose-TNE gradients while the less density
particles banded at 20%-30% sucrose-TNE gradients. The
purity of IBV was confirmed by electron microscopy
analysis following negative staining to ensure that the
virions have normal viral morphology and to exclude the
possible inclusions of vesicles, other cellular organelles
and debris (Fig. 1A). An abundance of intact virions were
observed without obvious contamination from host cellu-
lar materia. Proteins in purified virions were separated on
12% Sodium dodecylsulfate polyacrylamide gel electro-
phoresis (SDS-PAGE) and stained withc coomassie bril-
liant blue (Fig. 1B). There were also some lighter bands
visible that may represent cellular proteins besides the
conjectured major virus-encoded structural proteins.
Furthermore, the four virus-encoded structural proteins
were confirmed by immunoblotting test (Fig. 1C). Taken
together, the best purification of the IBV was obtained
after differential centrifugation to remove the cellular
contamination and condensation through a 20% (wt/vol)
sucrose cushion with a non-linear sucrose gradient.
Proteomic analysis of purified IBV particles
To obtain a detailed protein composition profile associ-
ated with the IBV particles, the proteins in purified IBV
particles were extracted for 2-DE experiments. To
authenticate the results and to compensate the variability
Figure 1 Analysis of purified avian infectious bronchitis virus 
preparations. A: specific pathogen free (SPF) chick embryo-grown 
major particles H52 from 30%-40% sucrose density gradients, nega-
tively stained with 2% potassium phosphotungstate, pH 6.5. B: SDS-
PAGE separation of proteins in a purified H52 preparation. 8 μg of pro-
teins were separated on an 5-17.5% polyacrylamide gel and stained 
with Coomassie blue. C: Western blotting of the purified H52 virions. Vi-
ral proteins were separated on 12% polyacrylamide gel and analyzed 
by western blot with chicken polyclonal antibody against infectious 
bronchitis virus (Massachusetts). The identified viral proteins are indi-
cated. S: spike, N: nuclecapsid, M: mebrane, E: envelope.Kong et al. Proteome Science 2010, 8:29
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of gel electrophoresis, three independent experiments
were performed with three replicate gels for each experi-
ment. The viral protein profiles were analyzed by 2-D
with 250 μg of protein. After the electrophoresis separa-
tion, gels were stained with silver and processed for
image analysis. For IBV particle-associated proteins sepa-
rated in the pH3-10 range, 88 protein spots were detected
(Fig. 2).
Identification and classification of IBV-associated proteins
To identify the proteins associated with IBV particles, all
protein spots detected in the gels were excised and in-gel
digested with trypsin followed by MALDI-TOF/TOF
(Matrix-assisted laser desorption/ionizationtime of flight
mass spectrometry) analysis. Database search analysis
revealed that 2 virus-encoded structural proteins and 60
host proteins were successfully identified. Detailed infor-
mation of the full set of the identified proteins is listed in
Table 1; additional file 1.
To better understand the host proteins incorporated
with IBV virion and their roles played in IBV infection,
these proteins were categorized with biological processes
according to Uniprot Knowledge database (Swiss-Prof/
TrEMBL) and Gene Ontology Database. The identified
60 host proteins were comprised of cytoskeleton pro-
teins, molecular chaperone, macromolecular biosynthesis
proteins, signal transport proteins and glycolytic enzymes
(Table S1; additional file 1). These host proteins were
located mainly in the cytoplasm, including cytoskeleton,
cytosol and mitochondrion (Fig. 3).
Confirmation of cellular protein incorporated into IBV 
particles
To confirm the presence of host proteins in the purified
IBV particles after the identification of them by pro-
teomic method, we performed immunoblotting experi-
ments. IBV preparation purified from AF was analyzed
for the presence of N protein, actin, HSP90, annexin A2
and tubulin (Fig. 4). Extracts from 10-day-old specific
pathogen free (SPF) embryonated chicken eggs were
included as a positive control. When analyzing the results
of virion proteomic studies, the challenge is to prove that
the host proteins are really an part of the virion and that
Figure 2 Two-dimensional gel electrophoresis profiles of pro-
teins in purified infectious bronchitis virus particles. Arabic num-
bers indicate the protein spots; Arabic numbers with line indicate the 
failed identified protein spots.
Figure 3 Subcellular location and functional category of the iden-
tified host proteins. (A) Subcellular location; (B) Functional category.
Figure 4 Confirmation of host proteins incorporated into infec-
tious bronchitis virus particles with western blotting. 8 μg of puri-
fied virions from allantoic fluid (AF) (lane 1) and 15 μg of proteins 
extracted either from the normal 10-day-old specific pathogen free 
(SPF) chick embryo(CEL)(lane 2) or from the AF of the uninfected 10-
day-old specific pathogen free (SPF) embryonated chicken eggs which 
were parallelly subjected to our standard density centrifugation proce-
dure (lane 3) were subjected to western blot analysis with antibodies 
against the following proteins: (A) Actin, (B) Nucleocapsid (N) protein 
of the IBV, (C) Tubulin alpha-1, (D) Annexin A2, (E) Hsp90. Numbers to 
the left are molecular weight markers (M).Kong et al. Proteome Science 2010, 8:29
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they are not just attached non-specifically to the outside
of the virus. To address this question, the AF from unin-
fected 10-day-old SPF embryonated chicken eggs were
parallelly subjected to our standard density centrifuga-
tion procedure and the protein extracts from 30%-40%
sucrose gradient was used as negative control. Gradient-
purified virions and the control were separated on 12%
SDS-PAGE gels, transferred to PVDF membranes, and
probed with the appropriate antibodies. As shown in Fig.
4, actin, tubulin and annexin A2 were both found in the
purified virions and positive control but not in the AF
extracts from uninfected 10-day-old SPF embryonated
chicken eggs. HSP90 is a member of the heat shock pro-
tein family which is upregulated in response to stress and
has low abundance in unstressed cells. In present study,
we detected it only in the purified virions but not in nor-
mal cells. It is an expectable result that we also detected
actin and tubulin in the AF extracts from uninfected 10-
day-old SPF embryonated chicken eggs which resulted
from their high concentrations in all eukaryotic cells and
subcellular fractions.
To provide additional evidence that the host proteins
are not just derived from a microvesicle or exosome that
co-purified with the virus, we used the bromelain pro-
tease protection assay which has been shown to effi-
ciently remove microvesicles from IBV virion
preparations[25]. Protease treatment of the purified virus
preparation strips proteins off any contaminating
microvesicles and off the outside of virus particles, such
as S protein. In doing so, the microvesicles become
lighter than the virions and therefore the virions can be
isolated by density centrifugation. Proteins that are inside
the virion are protected by the lipid envelope and there-
fore will remain after the protease treatment. And then
immunogold labeling of the purified virions was per-
formed (Fig. 5). Virions were either mock treated or sub-
jected to digestion with bromelain and then were
incubated with antibodies against actin, annexin A2,
HSP90, IBV Massachusetts strain and secondary gold
antibodies followed by negative staining. One or two gold
particles located on the surface of a virion could be seen
for HSP90. This was significantly less compared with the
degree of other labelings which is consistent with the fact
that there is most likely far more actin, annexin A2 pres-
ent on the virions than HSP90. In addition, the abun-
dance of actin detected in the 2-DE gels is much higher
than that of HSP90.
Discussion
Virus exploits multiple host proteins during infection for
successful entry, replication, egress, and evasion. This is
especially true for RNA viruses because they encode only
little proteins. Learning the protein composition profile
of the infectious viral particle is prerequisite for studying
the role of host proteins during infection. To our knowl-
edge, incorporation of host proteins in the enveloped-
virus family Coronaviridae has not been investigated so
f a r .  I n  t h i s  s t u d y ,  w e  r e v e a l e d  t h e  p r e s e n c e  o f  v i r u s -
encoded proteins in infectious bronchitis particles and
for the first time confirmed the incorporation of host
proteins. A total of 2 viral and 60 host proteins associated
with purified IBV particles were identified.
In the present study, we failed to obtain M and E pro-
tein while other two structural proteins N and S were
identified successfully. N protein is easy to identify
because it is the most abundant virus-derived protein
produced throughout the process of the virus infection,
whereas S protein as a major structural protein of IBV
located on the surface of viral particles is also easy for
identification because it is large (about 175 kDa) and has
many tryptic cleavage peak in the MS analysis. The iden-
tification of M and E protein of coronavirus by MS has
been thought to be a difficult task due to their properties,
especially in the case of E protein for the following rea-
sons [26]. First, E protein is a very hydrophobic protein.
Second, it is low-abundant in the virions. Third, E is a low
molecular weight protein with the mass about 12 kDa.
Fourth, E protein contains two cysteines, which may form
disulfide bonds within itself or with other proteins and
make E protein difficult to be reduced and subsequently
digested.
Figure 5 Immunogold labeling of host proteins in purified infec-
tious bronchitis virus (IBV) particles. Purified IBV particles were ei-
ther mock treated (A) or subjected to digestion with bromelain (B-F) 
followed by concentration through a sucrose cushion and then immu-
nogold labeled with antibodies against (A) IBV mock, (B) IBV, (C) normal 
mouse IgG, (D) Actin, (E) Annexin A2, (F) Hsp90. Labeled virions were 
fixed in 2% paraformaldehyde for 5 min at RT and treated with Triton 
X-100 (0.2%) in PBS (pH 7.4) for 5 min and then blocked with 5% BSA in 
PBS-Tween 20 (pH 7.4) for 30 min at RT. After being incubated with pri-
mary and secondary antibody, the virions were negatively stained with 
2% sodium phosphotungstate and visualized by electron microscopy 
(30,000 × magnification). Arabic numbers shown outside the blanket 
indicate the quantity of gold particles per virion while numbers shown 
inside the blanket indicate the quantity of virions counted.Kong et al. Proteome Science 2010, 8:29
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Of the total host proteins, 39 have also been described
to be present in virions of quite diverse virus families,
such as herpesviruses, poxviruses, paramyxovirus and
retroviruses [27,28]. There are some explanations that the
incorporated host proteins are common to other virus
families. First, they are all enveloped viruses. Enveloped
viruses contain the viral genome and core proteins
wrapped within one or more membranes which are
acquired from the host cell during virus assembly and
budding. These viruses all share some fundamental fea-
ture in the particular stage of their life-cycle and these
host proteins are involved in the common process. Sec-
ond, these host proteins would be either highly abundant
cytosolic proteins or enriched at the virus budding sites.
Several of the highly abundant cytosolic proteins found
within both IBV and other viral particles are beta actin,
tubulin, annexins and enolase. Proteins enriched at the
virus budding sites including HSP70, HSP90 and GAPDH
are also identified in IBV and other viruses
[9,11,12,14,19,24].
Some host proteins may be specially incorporated into
the virions. In this study, 21 of the total host proteins are
reported for the first time. The identified host protein
functions in diverse biological processes and some func-
tional groups are analyzed. These proteins participate in a
broad array of cellular functions and are involved in many
processes in the viral life cycle. The potential roles of
some of these proteins are discussed below in relation
with IBV infection, pathogenesis and early host antiviral
response.
Numerous viral proteins interact with cytoskeletal ele-
ments. Many viruses, such as retroviruses, herpesviruses
and picornaviruses, even contain the main cytoskeletal
element actins in their infectious particles. The transport
machinery of actins are proven to be critical at almost
every step along the infectious cycle [29]. Actin has been
found in preparations from several types of retroviruses
and paramyxoviruses. For coronavirus, an association of
M with cytoskeletal elements has been reported [5],
which indicates an essential function of actin in the repli-
cation cycle of coronavirus IBV. In our studies, actin and
tubulin were all present in the interior of infectious bron-
chitis particles and this observation most likely reflects
their active participation in moving the viral components
to assembly sites. Actin and tubulin have been character-
ized as the major folding substrates for CCT (Chaperonin
containing TCP-1, also termed TRiC). Both cytoskeletal
proteins require in vivo and in vitro the interaction with
CCT to fold to their native states [30]. CCT is the most
different and complicated protein of all group II chaper-
onins in eukaryotic cytosolic chaperonins, which might
be involved in the assistance of the folding of a small set
of proteins. In addition to the already mentioned actin
and tubulin, CCT has been found to interact either in
vitro or in vivo with other cytoskeletal proteins, cell divi-
sion control protein 20, protein phosphatase type 2A, and
guanine nucleotide-binding protein (G protein) beta sub-
unit [31], which are all found to be associated with infec-
tious bronchitis particles in present study. It's pleasantly
surprising to find that certain viral proteins such as the
Epstein Barr virus-encoded nuclear protein (EBNA-3),
the hepatitis B virus capsid and the type D retrovirus Gag
polyprotein are also folded by CCT [32-34]. Thus, CCT
may have an important role in infectious bronchitis viral
proteins assembly.
Other cytoskeletal proteins found to be associated with
infectious bronchitis particles are actin-related proteins,
WD repeat containing protein, destrin and annexin. Sev-
eral annexin family members (A2, A5 and A11) were
identified in purified infectious bronchitis particles.
Annexins are a well-known multigene family of Ca2+ reg-
ulated phospholipid-binding and membrane binding pro-
teins with diverse functions. The presence of annexin A2
is thought to support viral binding, fusion and replication
[35-39]. Annexin A5, which interacts with annexin A2,
has the opposite effect by preventing fusion, which possi-
bly indicates a potential regulatory role [38]. Annexin A2
tightly binds to a member of the S100 family of calcium-
binding proteins, S100A10 (p11). Upon binding, annexin
A2 and p11 form a heterotetramer which is capable of
binding two membrane surfaces simultaneously, which
potentially promotes fusion events and also plays a role in
exocytosis [40]. The p11 protein was also detected by our
analysis, suggesting that IBV is also incorporated this
complex. Other S100 family members such as S100A6
and S100A11 were also detected in viral samples and
could play various roles in fusion and membrane organi-
zation [41,42].
Heat-shock proteins (HSPs) have been known as multi-
functional proteins. They facilitate the folding and
unfolding of proteins, participate in vesicular transport
processes, prevent protein aggregation in the densely
packed cytosol and are involved in signaling processes.
Most, but not all, HSPs are molecular chaperones. Sev-
eral viruses require host molecular chaperones for entry,
replication, and assembly, as well as other steps in viral
production [43,44]. HSP70 and HSP90 have been found
incorporated into IBV. HSP70 interacts with various viral
proteins and may be involved in the assembly of adenovi-
rus [45], enterovirus [46], vaccinia virus [47] and hantaan
virus [48]. Alternatively, upon entry into susceptible tar-
get cells, virion-associated HSP70 might participate in
early events of infection. For example, HSP70 might
actively uncoat the viral capsid in a manner similar to its
role in the uncoating of clathrin cages [49]. HSP70 and
HSP90 have been shown to interact with hepatitis B virus
reverse transcriptase and to facilitate the initiation of
viral DNA synthesis from hepatitis B virus pregenomicKong et al. Proteome Science 2010, 8:29
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RNA [50,51]. For sendai virus (SV), the viral proteins syn-
ethsis will be inhibited as long as HSP70 synthesis occurs
[52]. Thus, HSP70 in IBV virions might serve a similar
function in the virus life cycle. The chaperone HSP90 has
been identified as an essential factor in the folding and
maturation of picornavirus capsid proteins [53]. The
involvement of HSP90 in viral replication has also been
reported for many viruses and it has been demonstrated
that HSP90 inhibition blocks viral replication [54].
Recently, a role for HSP90 in the control of hepatitis C,
flock house and influenza virus polymerase function has
been shown [55-61] and it has been proposed that HSP90
is a major host factor that is of central importance for
viral replication for a wide spectrum of RNA viruses [56],
which implies the crucial roles of HSP90 in IBV replica-
tion. The importance of HSP90 for the replication of mul-
tiple viruses opens up an interesting possibility for
developing new antiviral therapies which have not yielded
drug-resistant viruses [62].
Some proteins involved in the glycolytic pathway were
identified, such as aldehyde dehydrogenase 9 family,
member A1 (ALDH9A1), glyceraldehyde-3-phosphate
dehydrogenase (GAPDH), alpha-enolase, which were
identified in other viral particles, like HIV-1, MMLV,
HCMV, KSHV and AIV [8,12,19,21,24]. Some studies
have suggested that several glycolytic enzymes interact
with microtubules and tubulin [63-65] and may also con-
tribute to transcription of RNA virus genomes. In higher
eukaryotes, enolase is found as a dimer of subunits, α, β,
or γ. All enolase isoforms from mammalian have been
reported that are capable of stimulating transcription of
SVgenome [66]. GAPDH is a well-characterized key
enzyme in glycolysis, but recent evidence suggests it also
has RNA binding properties and binds to the untrans-
lated RNA sequences of several different viruses, includ-
ing human parainfluenza virus type 3(hPIV3), Japanese
encephalitis virus (JEV), hepatitis A virus (HAV) and
hepatitis B virus (HBV) as well as hepatitis C virus (HCV)
[67-71]. In the case of hPIV3, GAPDH has been reported
to inhibit actin-dependent in vitro transcription and is
also present in purified virions [67,72]. In vitro data indi-
cates that GAPDH serves a negative regulatory role in
hPIV3 transcription and in a phosphorylation-dependent
on manner [72].
In addition to these host proteins associated with envel-
oped viruses, the roles of which in the virus life cycles
have been studied well, we also identified 21 host proteins
in purified infectious bronchitis particles, which have not
been described to be present in other virions of quite
diverse virus families, such as apolipoprotein A-I (apoA-
I), fatty acid-bingding protein 3, ovalbumin, TENP pro-
tein, tumor protein translationally controlled-1, transthy-
retin and so on. ApoA-I, a major constituent of high-
density lipoproteins, alters plasma membrane morphol-
ogy by participating in the reverse transport of choles-
terol binding with ATP-binding cassette transporter A1
[73], and activates the small GTP-binding protein cdc42-
associated signaling including apoA-I induced cholesterol
efflux, protein kinases, and actin polymerization [74].
What important is that apo A-I can inhibit herpes sim-
plex virus (HSV)-induced cell fusion at physiological con-
centrations. This function may be related to the structure
of apoA-I and before long its amphipathic peptide ana-
logue was also found to inhibit cell fusion, both in HIV-1-
infected T cells and in recombinant vaccinia-virus-
infected CD4+ HeLa cells expressing HIV envelope pro-
tein on their surfaces [75]. The results indicate that
amphipathic helices may be useful in designing novel
antiviral agents that inhibit penetration and spreading of
enveloped viruses. Ovalbumin is the main protein found
in egg white, making up 60-65% of the total protein. The
chicken ovalbumin upstream promoter transcription fac-
tors (COUP-TFs), members of the steroid/thyroid hor-
mone receptor superfamily, binds to a negative regulatory
region in the human immunodeficiency virus type 1 long
terminal repeat (LTR). LTR contains a negative regulatory
element which downregulates the rate of LTR-directed
transcription and HIV-1 replication [76]. The interaction
between ovalbumin and NP from influenza A virus as
well as glycoprotein C from the herpes simplex type I
virus was reported long time ago [76]. The TENP protein
from  G. gallus, however, was isolated as a transiently
expressed gene in neural precursor cells in retina and
brain, and has been proposed to function in the transition
to cell differentiation in neurogenesis. After expressed in
chicken embryonic fibroblast cells, TENP was immuno-
detected in membrane fractions, implying that TENP
might be a membrane protein as predicted by a computer
analysis of its primary sequence [77]. To date, there have
been no reports about TENP associated with virus, but
it's an enriched and abundant protein identified in puri-
fied infectious bronchitis particles which suggests to us
that it may be a requisite host protein in IBV life cycles.
Conclusions
The present study 1) provides the first proteomic analysis
of infectious bronchitis particles, 2) establishes the most
comprehensive proteomic index of IBV and 3) shows that
most of the virion incorporated host proteins have cen-
tral roles in virus life cycle. Although some proteins may
be associated with virus biology, further investigation of
the function of these host proteins may facilitate the
understanding of the pathogenic mechanisms.
Methods
Propagation and purification of IBV
The IBV strain H52 was obtained from Qianyuanhao Bio-
logical Corporation Limited (Beijing, China). Virus wasKong et al. Proteome Science 2010, 8:29
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propagated in 10-day-old specific pathogen free (SPF)
embryonated chicken eggs (Beijing Merial Vital Labora-
tory Animal Technology Co, Ltd, Beijing, China) for 48 h
at 37°C. The allantoic fluid (AF) with enrichment of IBV
H52 was clarified by differential centrifugation. AF was
first centrifugated at 3,000 × g for 30 min and then the
supernatant was centrifugated at 12,000 × g for 30 min.
Clarification and all subsequent centrifugations were per-
formed at 4°C. The virus was sedimented through 5.5 ml
of 20% (wt/vol) sucrose in TNE buffer (50 mM Tris, 100
mM NaCl, 1 mM EDTA, pH 7.4) by centrifugation in a
70Ti rotor (Beckman Coulter, Optima™ L-100XP Prepara-
tive ultracentrifuge) at 75,000 × g for 1.5 h. Condensed
Virions were then diluted with 1.0 ml TNE buffer and
centrifuged to equilibrium in 11.5 ml non-linear 20%-50%
sucrose-TNE gradients at 75,000 × g for 2.5 h in a SW41
rotor (Beckman Coulter, Optima™ L-100XP Preparative
ultracentrifuge). Purified virions were diluted with TNE
buffer and pelleted by sedimentation at 75,000 × g for 1.5
h in a SW41 rotor to remove the sucrose. The purified
IBV pellets were stored at -80°C until use.
Sample preparation
The purified IBV particles were dissolved in about 300 μl
lysis buffer (7 M urea, 2 M thiourea, 2% Triton X-100, 65
mM DTT, 2% Biolyte pH 3-10) and incubated for 60 min
at 4°C. Then the lysis solution was sonicated for 4 min
(pulse durations of 2 s on and 3 s off) in an ice bath soni-
cator. The viral protein samples were prepared when the
indiscerptible sediments were wiped off by centrifugation
at 12,000 × g for 30 min. The supernatant was collected
and the concentration of the prepared protein samples
was determined by the Bio-Rad protein assay kit II
according to the manufacturer's instructions. The sam-
ples were then aliquoted and stored at -80°C until used
for further analysis.
Protease treatment of virions
Purified virus particles treated with bromelain (BB0243,
BBI) at 0.2 mg/ml in 50 mM DTT (pH 7.2) in Dulbecco's
phosphate buffered saline (PBS) at 37°C for 15 min. After
incubation, the treated virus was directly centrifuged to
equilibrium in 11.5 ml non-linear 20%-50% sucrose-TNE
gradients at 75,000 × g for 2.5 h in a SW41 rotor (Beck-
man Coulter, Optima™ L-100XP Preparative ultracentri-
fuge). Purified virions were diluted with TNE buffer and
pelleted by sedimentation at 75,000 × g for 1.5 h in a
SW41 rotor to remove the sucrose and then subjected to
immunogold labeling and electron microscopy analysis.
Two-dimentional gel electrophoresis (2-DE) and silver 
staining
Two-dimentional gel electrophoresis analysis was per-
formed using 18 cm immobile DryStrip (IPG strips, pH 3-
10 non-linear, GE Healthcare). First, 100 μl samples con-
taining 250 μg protein were added into 400 μl sample
rehydration buffer (7 M urea, 2 M thiourea, 2% (w/v)
CHAPS, 65 mM DTT, 0.2% Bio-lyte pH 3-10) and incu-
bated for 30 min at 37°C prior to their separation by iso-
electric focusing (IEF) in the first dimension. The IPG
strips were rehydrated at 20°C for 12 h by a passive rehy-
dration method. IEF was carried out for a total of 45 kvh
at 20°C on an Ettan IPGphor III electrophoresis unit (GE
Healthcare). Second, IPG strips were further transferred
onto the second dimension of gel electrophoresis. Before
this step the IPG strips were reduced and alkylated in a
equilibration buffer containing 50 mM Tris-HCl, pH 8.6,
6 M urea, 2% SDS and 30% glycerol supplemented with
1% (w/v) DL-Dithiothreitol (DTT) or 2.5% iodoacetamide
(IAA) instead of DTT for 15 min. Subsequently, the viral
protein samples were separated at 140 V on linear 5%-
17.5% Sodium dodecyl sulfate gradient polyacrylamide
gel (SDS-PAGE) in Tris: glycine buffer (192 mM glycine,
25 mM Tris, 0.1% SDS, pH 8.3) for about 10 h. Third, pro-
teins in the gel were stained by the modified silver stain-
ing method compatible with MS [78] and the gels were
scanned at a resolution of 600 dpi using ImageScanner™
III (GE Healthcare).
Tryptic digestion and MALDI-TOF/TOF analysis of peptide
Gel pieces (1.0 mm3) containing the whole protein spots
from the 2D gel were cut and washed three times with 50
mM carbonic acid, monoammonium salt (NH4HCO3,
Amresco). These gel pieces were destained with 15 mM
potassium ferricyanide (K3Fe(CN)6, Amresco) and 50
mM sodium thiosulfate (NaS2O3,  A m r e s c o )  i n  5 0  m M
NH4HCO3 and dehydrated in 100% acetonitrile (ACN,
Wako) until gel pieces turn to white. After dring in
SpeedVac concentrator (Thermo Savant, USA) for about
100 min, gel pieces were incubated with 12.5 ng/μl
trypsin (Sequenceing grade, Promega) to cover dry gel
pieces completely at 37°C overnight. The gel pieces were
then extracted three times in 50% ACN water solution
containing 5% trifluoroacetic acid (TFA, Wako). The
supernatant was pooled and dried thoroughly in Speed-
Vac. Protein digestion extracts were resuspended with 5
μl of 0.1% TFA and then the peptide samples were mixed
(1:1) with a matrix consisting of a saturated solution of α-
cyano-4-hydroxycinnamic acid (α-CCA, Sigma) in 50%
ACN containing 0.1% TFA. 0.8 μl aliquot was spotted
onto stainless steel target plates. Peptide mass spectra
were obtained on an Applied Biosystem/MDS SCIEX
4800 MALDI TOF/TOF plus mass spectrometer. Data
were acquired in positive MS reflector using a CalMix5
standard to calibrate the instrument (ABI4800 Calibra-
tion Mixture). Mass spectra were obtained from each
sample spot by accumulation of 900 laser shots in an 800-Kong et al. Proteome Science 2010, 8:29
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3500 mass range. For MS/MS spectra, the 5-10 most
abundant precursor ions per sample were selected for
subsequent fragmentation and 1200 laser shots were
accumulated per precursor ion. Both the MS and MS/MS
data were interpreted and processed by GPS Explorer
software (V3.6, Applied Biosystems), then those obtained
MS and MS/MS spectra per spot were combined and
submitted to MASCOT search engine (V2.1, Matrix Sci-
ence, London, U.K.) by GPS Explorer software and
searched with the following parameters: trypsin as the
digestion enzyme, one missed cleavage site, partial modi-
fication of cysteine carboamidomethylated and methion-
ine oxidized, none fixed modifications, MS tolerance of
60 ppm, MS/MS tolerance of 0.25 Da. MASCOT protein
score in IPI_CHICKEN (V3.49) database (based on com-
bined MS and MS/MS spectra) of greater than 57 (p ≤
0.05) or in NCBInr database of greater than 67 (p ≤ 0.05)
was accepted.
Western blotting analysis
Mouse monoclonal antibodies against actin (MAB1501)
and HSP90 (05-594) were purchased from millipore. Rab-
bit polyclonal antibodies against Annexin A2 (ab40943)
and Tubulin alpha-1 (ab4074), and chicken polyclonal
antibody against IBV (Massachusetts) (ab31671) were
purchased from Abcam. Mouse monoclonal antibody
against nucleoprotein of IBV (3BN1) was purchased from
HyTest Ltd. For control, the AF from 10-day-old SPF
embryonated chicken egg performed with the same pro-
tocol as the purification of IBV particles and the protein
extracted from the normal 10-day-old SPF embryonated
chicken eggs included for western blot analysis. Samples
were separated at 120 V on linear 5%-17.5% SDS-PAGE
with 5% stacking gels in Tris: glycine buffer for about 3 h.
For purified virus, 10 μg of total proteins were used per
lane. For the control, a total of 15 μg proteins were
loaded. After separated by SDS-PAGE, the proteins were
transferred to a polyvinylidene fluoride membrane
(PVDF, P/N 66485, BioTrace, Pall Corporation). The
membrane was blocked in freshly prepared 5% bovine
serum albumin (BSA) with 0.05% Tween-20 for 2 h at
room temperature with constant agitation. The PVDF
membrane was washed three times with Tris buffered
saline plus 0.2% Tween 20 (TBST) and then incubated
with properly diluted primary antibodies for 2 h at room
temperature or overnight with agitation at 4°C. Anti-rab-
bit or anti-mouse immunoglobulin G antibody conju-
gated to horseradish peroxidase (HRP) (00001-14,
Proteintech Group, Inc) was used as the secondary anti-
body and the PVDF membrane was incubated in it for 1 h
at room temperature. The chemiluminescence system
(AR1022, Boster Bio-Technology Co. LTD) was used for
detection of antibody-antigen complexes.
Immunogold labeling and electron microscopy
Rabbit polyclonal antibody against chicken IgG (15 nm
Gold) (ab41500), goat polyclonal against rabbit IgG (5 nm
Gold) (ab27235) and goat polyclonal against mouse IgG
(10 nm Gold) (ab27241) were purchased from Abcam.
Purified IBV particles were suspended in PBS (pH 7.4)
and then were collected onto 230-mesh formwar-coated
nickel grids and adsorbed on the grids for 5 min. The
viruses were fixed in 2% paraformaldehyde for 5 min at
RT and treated with Triton X-100 (0.2%) in PBS (pH 7.4)
for 5 min and then blocked with 5% BSA in PBS-Tween
20 (pH 7.4) for 30 min at RT. All grids were then blocked
with blocking buffer (5% BSA, 5% normal serum, 0.1%
cold water skin gelatin, 10 mM phosphate buffer, 150 mM
NaCl, pH 7.4) for 30 min. After washing with PBS, immo-
bilized virions were incubated for 1.5 h with 50 μg/ml pri-
mary antibody (in 1% BSA), and washed three times for 5
min in PBS/1% BSA. Anti-rabbit or anti-mouse immuno-
globulin G coupled to 10 nm colloidal gold particles was
used as the secondary antibody and virions were incu-
bated in it for 40 min at room temperature. The grids
w e r e  t h e n  w a s h e d  e x t e n s i v e l y  w i t h  P B S ,  w a s h e d  t w i c e
more with distilled water to remove excess salt and nega-
t i v e l y  s t a i n e d  w i t h  2 %  s o d i u m  p h o s p h o t u n g s t a t e  f o r  1
min. Negatively stained virions were examined on a scan
and transmission electron microscope.
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